Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Opening the black box: Examining the nomological network of work ability and its role in organizational research.

Brady GM, Truxillo DM, Cadiz DM, Rineer JR, Caughlin DE, Bodner T.

J Appl Psychol. 2019 Oct 24. doi: 10.1037/apl0000454. [Epub ahead of print]

PMID:
31647249
2.

Creation of a Geospatially Explicit, Agent-based Model of a Regional Healthcare Network with Application to Clostridioides difficile Infection.

Rhea S, Hilscher R, Rineer JI, Munoz B, Jones K, Endres-Dighe SM, DiBiase LM, Sickbert-Bennett EE, Weber DJ, MacFarquhar JK, Dubendris H, Bobashev G.

Health Secur. 2019 Jul/Aug;17(4):276-290. doi: 10.1089/hs.2019.0021.

PMID:
31433281
3.

Forecasting the Impact of Maternal Undernutrition on Child Health Outcomes in Indonesia [Internet].

Cooley PC, Poulos C, Rineer JI, Rogers SM, Scruggs MD, Wagener DK, Wheaton WD, Lee BY.

Research Triangle Park (NC): RTI Press; 2016 Dec.

4.

Comparing medical and recreational cannabis use among employees: associations with health and work-related outcomes.

Rineer JR, Duhart Clarke S, Cluff LA, Peiper NC.

Int Rev Psychiatry. 2018 Jun;30(3):268-276. doi: 10.1080/09540261.2018.1465397.

PMID:
30179533
5.

Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.

Osborn VW, Givi B, Rineer J, Roden D, Sheth N, Lederman A, Katsoulakis E, Hu K, Schreiber D.

Head Neck. 2018 Jun;40(6):1254-1262. doi: 10.1002/hed.25103. Epub 2018 Feb 16.

PMID:
29451961
6.

Patterns of Progression in Metastatic Estrogen Receptor Positive Breast Cancer: An Argument for Local Therapy.

Kelly P, Ma Z, Baidas S, Moroose R, Shah N, Dagan R, Mamounas E, Rineer J.

Int J Breast Cancer. 2017;2017:1367159. doi: 10.1155/2017/1367159. Epub 2017 Sep 25.

7.

Building Capacity for Workplace Health Promotion: Findings From the Work@Health® Train-the-Trainer Program.

Lang J, Cluff L, Rineer J, Brown D, Jones-Jack N.

Health Promot Pract. 2017 Nov;18(6):902-911. doi: 10.1177/1524839917715053. Epub 2017 Aug 22.

8.

Training Employers to Implement Health Promotion Programs: Results From the CDC Work@Health® Program.

Cluff LA, Lang JE, Rineer JR, Jones-Jack NH, Strazza KM.

Am J Health Promot. 2018 May;32(4):1062-1069. doi: 10.1177/0890117117721067. Epub 2017 Jul 21.

9.

A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012.

Fogh SE, Deshmukh S, Berk LB, Dueck AC, Roof K, Yacoub S, Gergel T, Stephans K, Rimner A, DeNittis A, Pablo J, Rineer J, Williams TM, Bruner D.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):786-796. doi: 10.1016/j.ijrobp.2016.11.022. Epub 2016 Nov 23.

10.

Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.

Wong AT, Shao M, Rineer J, Osborn V, Schwartz D, Schreiber D.

Dis Esophagus. 2017 Feb 1;30(2):1-5. doi: 10.1111/dote.12487.

PMID:
27860114
11.

Patterns of adjuvant radiation usage and survival outcomes for stage I endometrial carcinoma in a large hospital-based cohort.

Wong AT, Rineer J, Schwartz D, Weiner J, Safdieh J, Choi K, Schreiber D.

Gynecol Oncol. 2017 Jan;144(1):113-118. doi: 10.1016/j.ygyno.2016.11.003. Epub 2016 Nov 4.

PMID:
27823769
12.

Effect of Thoracic Radiotherapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma.

Wong AT, Rineer J, Schwartz D, Becker D, Safdieh J, Osborn V, Schreiber D.

Clin Lung Cancer. 2017 Mar;18(2):207-212. doi: 10.1016/j.cllc.2016.07.009. Epub 2016 Aug 8.

PMID:
27686970
13.
14.

Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma.

Wong AT, Rineer J, Lee YC, Schwartz D, Safdieh J, Weiner J, Choi K, Schreiber D.

Gynecol Oncol. 2016 Sep;142(3):514-9. doi: 10.1016/j.ygyno.2016.07.091. Epub 2016 Jul 14.

PMID:
27421751
15.

The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma.

Wong AT, Shao M, Rineer J, Lee A, Schwartz D, Schreiber D.

Ann Surg. 2017 Jun;265(6):1146-1151. doi: 10.1097/SLA.0000000000001825.

PMID:
27280504
16.

Assessing the Impact of Postoperative Radiation Therapy for Completely Resected Limited-Stage Small Cell Lung Cancer Using the National Cancer Database.

Wong AT, Rineer J, Schwartz D, Schreiber D.

J Thorac Oncol. 2016 Feb;11(2):242-8. doi: 10.1016/j.jtho.2015.10.011. Epub 2015 Dec 19.

17.

Effects of a Workplace Intervention Targeting Psychosocial Risk Factors on Safety and Health Outcomes.

Hammer LB, Truxillo DM, Bodner T, Rineer J, Pytlovany AC, Richman A.

Biomed Res Int. 2015;2015:836967. doi: 10.1155/2015/836967. Epub 2015 Oct 18.

18.

Does the Presence of a Major Psychiatric Disorder Affect Tolerance and Outcomes in Men With Prostate Cancer Receiving Radiation Therapy?

Safdieh JJ, Schwartz D, Rineer J, Weiner JP, Wong A, Schreiber D.

Am J Mens Health. 2017 Jan;11(1):5-12. doi: 10.1177/1557988315610626. Epub 2016 Jun 23.

19.

Utilization of Hyperfractionated Radiation in Small-Cell Lung Cancer and Its Impact on Survival.

Schreiber D, Wong AT, Schwartz D, Rineer J.

J Thorac Oncol. 2015 Dec;10(12):1770-5. doi: 10.1097/JTO.0000000000000672.

20.

A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer.

Wong AT, Safdieh JJ, Rineer J, Weiner J, Schwartz D, Schreiber D.

Int Urol Nephrol. 2015 Oct;47(10):1629-34. doi: 10.1007/s11255-015-1096-8. Epub 2015 Sep 2.

PMID:
26329748
21.

Clinical and biochemical outcomes of men undergoing radical prostatectomy or radiation therapy for localized prostate cancer.

Schreiber D, Rineer J, Weiss JP, Safdieh J, Weiner J, Rotman M, Schwartz D.

Radiat Oncol J. 2015 Mar;33(1):21-8. doi: 10.3857/roj.2015.33.1.21. Epub 2015 Mar 31.

22.

A Population-Based Study of Men With Low-Volume Low-Risk Prostate Cancer: Does African-American Race Predict for More Aggressive Disease?

Schreiber D, Chhabra A, Rineer J, Weedon J, Schwartz D.

Clin Genitourin Cancer. 2015 Aug;13(4):e259-e264. doi: 10.1016/j.clgc.2015.02.006. Epub 2015 Feb 21.

PMID:
25777681
23.

Prostate biopsy concordance in a large population-based sample: a Surveillance, Epidemiology and End Results study.

Schreiber D, Wong AT, Rineer J, Weedon J, Schwartz D.

J Clin Pathol. 2015 Jun;68(6):453-7. doi: 10.1136/jclinpath-2014-202767. Epub 2015 Mar 11. Erratum in: J Clin Pathol. 2015 Jul;68(7):e2.

PMID:
25762729
24.

Radiation therapy for clinically localized prostate cancer: long-term results of 469 patients from a single institution in the era of dose escalation.

Surapaneni A, Schwartz D, Nwokedi E, Rineer J, Rotman M, Schreiber D.

J Cancer Res Ther. 2014 Oct-Dec;10(4):951-6. doi: 10.4103/0973-1482.138096.

25.

Assessment of risk of late rectal bleeding for patients with prostate cancer started on anticoagulation before or after radiation treatment.

Schreiber D, Chen SC, Rineer J, Worth M, Telivala T, Schwartz D.

Anticancer Res. 2014 Dec;34(12):7367-72.

PMID:
25503174
26.

Long-term tolerance and outcomes for dose escalation in early salvage post-prostatectomy radiation therapy.

Safdieh JJ, Schwartz D, Weiner J, Weiss JP, Rineer J, Madeb I, Rotman M, Schreiber D.

Radiat Oncol J. 2014 Sep;32(3):179-86. doi: 10.3857/roj.2014.32.3.179. Epub 2014 Sep 30.

27.

Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.

McAvoy S, Ciura K, Wei C, Rineer J, Liao Z, Chang JY, Palmer MB, Cox JD, Komaki R, Gomez DR.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):819-27. doi: 10.1016/j.ijrobp.2014.07.030. Epub 2014 Sep 11.

PMID:
25220718
28.

Contemporary analysis of pelvic and para-aortic metastasis in endometrial cancer using the SEER registry.

Katsoulakis E, Mattes MD, Rineer JM, Nabhani T, Mourad WF, Choi K, Schreiber D.

Int J Gynaecol Obstet. 2014 Dec;127(3):293-6. doi: 10.1016/j.ijgo.2014.06.022. Epub 2014 Aug 13.

PMID:
25194213
29.

Dose-escalated radiation therapy with and without short-course androgen deprivation for intermediate-risk prostate cancer.

Schreiber D, Rineer J, Surapaneni A, Navo E, Agarwal M, Nwokedi E, Rotman M, Schwartz D.

Anticancer Res. 2014 Aug;34(8):4189-93.

PMID:
25075045
30.

Impact of race in a predominantly African-American population of patients with low/intermediate risk prostate cancer undergoing radical prostatectomy within an equal access care institution.

Schreiber D, Levy EB, Schwartz D, Rineer J, Wong A, Rotman M, Weiss JP.

Int Urol Nephrol. 2014 Oct;46(10):1941-6. doi: 10.1007/s11255-014-0773-3. Epub 2014 Jun 27.

PMID:
24969031
31.

A margin-based analysis of the dosimetric impact of motion on step-and-shoot IMRT lung plans.

Waghorn BJ, Shah AP, Rineer JM, Langen KM, Meeks SL.

Radiat Oncol. 2014 Feb 5;9:46. doi: 10.1186/1748-717X-9-46.

32.

Outcomes and tolerance of human immunodeficiency virus--positive U.S. veterans undergoing dose-escalated external beam radiotherapy for localized prostate cancer.

Schreiber D, Chhabra A, Rineer J, Nabhani T, Katsoulakis E, Morkos R, Rotman M, Schwartz D.

Clin Genitourin Cancer. 2014 Apr;12(2):94-9. doi: 10.1016/j.clgc.2013.07.008. Epub 2013 Oct 28.

PMID:
24176940
33.

Racial and socioeconomic disparities in the selection of prostate brachytherapy.

Schreiber D, Chen SC, Rineer J, Weiss J, Rotman M, Schwartz D.

J Contemp Brachytherapy. 2013 Sep;5(3):139-43. doi: 10.5114/jcb.2013.37563. Epub 2013 Sep 12.

34.

Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer.

McAvoy SA, Ciura KT, Rineer JM, Allen PK, Liao Z, Chang JY, Palmer MB, Cox JD, Komaki R, Gomez DR.

Radiother Oncol. 2013 Oct;109(1):38-44. doi: 10.1016/j.radonc.2013.08.014. Epub 2013 Sep 7.

PMID:
24016675
35.

A comparison of the dosimetric effects of intrafraction motion on step-and-shoot, compensator, and helical tomotherapy-based IMRT.

Waghorn BJ, Staton RJ, Rineer JM, Meeks SL, Langen K.

J Appl Clin Med Phys. 2013 May 6;14(3):4210. doi: 10.1120/jacmp.v14i3.4210.

36.

A population-based comparison of overall and disease-specific survival following local excision or abdominoperineal resection for stage I rectal adenocarcinoma.

Olsheski M, Schwartz D, Rineer J, Wortham A, Sura S, Sugiyama G, Rotman M, Schreiber D.

J Gastrointest Cancer. 2013 Sep;44(3):305-12. doi: 10.1007/s12029-013-9493-7.

PMID:
23564262
37.

Real-time tumor tracking in the lung using an electromagnetic tracking system.

Shah AP, Kupelian PA, Waghorn BJ, Willoughby TR, Rineer JM, Mañon RR, Vollenweider MA, Meeks SL.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):477-83. doi: 10.1016/j.ijrobp.2012.12.030. Epub 2013 Mar 21.

PMID:
23523325
38.

Aortic dose constraints when reirradiating thoracic tumors.

Evans JD, Gomez DR, Amini A, Rebueno N, Allen PK, Martel MK, Rineer JM, Ang KK, McAvoy S, Cox JD, Komaki R, Welsh JW.

Radiother Oncol. 2013 Mar;106(3):327-32. doi: 10.1016/j.radonc.2013.02.002. Epub 2013 Feb 28.

39.

Editorial comment from Dr Schreiber and Dr Rineer to local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder.

Schreiber D, Rineer J.

Int J Urol. 2013 Aug;20(8):786-7. doi: 10.1111/iju.12059. Epub 2012 Dec 11. No abstract available.

40.

Characterization and outcomes of small cell carcinoma of the bladder using the surveillance, epidemiology, and end results database.

Schreiber D, Rineer J, Weiss J, Leaf A, Karanikolas N, Rotman M, Schwartz D.

Am J Clin Oncol. 2013 Apr;36(2):126-31. doi: 10.1097/COC.0b013e3182438c71.

PMID:
22391430
41.

Impact of adjuvant external-beam radiation therapy in early-stage uterine papillary serous and clear cell carcinoma.

Kim A, Schreiber D, Rineer J, Choi K, Rotman M.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e639-44. doi: 10.1016/j.ijrobp.2011.01.053. Epub 2011 Apr 18.

PMID:
21507584
42.

Impact of postoperative radiation on survival for high-grade soft tissue sarcoma of the extremities after limb sparing radical resection.

Schreiber D, Rineer J, Katsoulakis E, Sroufe RL, Lange CS, Nwokedi E, Schwartz D, Choi K, Rotman M.

Am J Clin Oncol. 2012 Feb;35(1):13-7. doi: 10.1097/COC.0b013e3181fe46d4.

PMID:
21278563
43.

Radical prostatectomy for cT3-4 disease: an evaluation of the pathological outcomes and patterns of care for adjuvant radiation in a national cohort.

Schreiber D, Rineer J, Sura S, Teper E, Nabhani T, Han P, Schwartz D, Choi K, Rotman M.

BJU Int. 2011 Aug;108(3):360-5. doi: 10.1111/j.1464-410X.2010.09875.x. Epub 2010 Nov 18.

44.

Analysis of pathologic extent of disease for clinically localized prostate cancer after radical prostatectomy and subsequent use of adjuvant radiation in a national cohort.

Schreiber D, Rineer J, Yu JB, Olsheski M, Nwokedi E, Schwartz D, Choi K, Rotman M.

Cancer. 2010 Dec 15;116(24):5757-66. doi: 10.1002/cncr.25561. Epub 2010 Aug 24.

45.

A Nationally consistent NHDPlus framework for identifying interstate waters: implications for integrated assessments and interjurisdictional TMDLs.

Cooter W, Rineer J, Bergenroth B.

Environ Manage. 2010 Sep;46(3):510-24. doi: 10.1007/s00267-010-9526-y. Epub 2010 Jul 13.

PMID:
20625899
46.

Characterization and outcomes of infratentorial malignant glioma: a population-based study using the Surveillance Epidemiology and End-Results database.

Rineer J, Schreiber D, Choi K, Rotman M.

Radiother Oncol. 2010 Jun;95(3):321-6. doi: 10.1016/j.radonc.2010.04.007. Epub 2010 May 5.

PMID:
20451276
47.

Mapping of Sample Collection Data: GIS Tools for the Natural Product Researcher.

Oberlies NH, Rineer JI, Alali FQ, Tawaha K, Falkinham JO 3rd, Wheaton WD.

Phytochem Lett. 2009 Feb 19;2(1):1-9.

48.

A nationally consistent framework for identifying interstate waters with applications for the national listing of fish advisories.

Cooter W, Cunningham P, Rineer J, Bergenroth B, Lin SY.

Environ Monit Assess. 2011 Jan;172(1-4):67-89. doi: 10.1007/s10661-010-1318-6. Epub 2010 Feb 3.

PMID:
20127407
49.

Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?

Schreiber D, Rineer J, Weedon J, Vongtama D, Wortham A, Kim A, Han P, Choi K, Rotman M.

Cancer. 2010 Mar 1;116(5):1350-7. doi: 10.1002/cncr.24853.

50.

Impact of postoperative radiation after esophagectomy for esophageal cancer.

Schreiber D, Rineer J, Vongtama D, Wortham A, Han P, Schwartz D, Choi K, Rotman M.

J Thorac Oncol. 2010 Feb;5(2):244-50. doi: 10.1097/JTO.0b013e3181c5e34f.

Supplemental Content

Loading ...
Support Center